Nuvation Bio Inc. short interest in 2023
In 2023, Nuvation Bio Inc.'s disclosed short interest ran from 0.88% of shares outstanding on 13 Jan 2023 to 1.08% on 29 Dec 2023, a change of +0.20 percentage points. The year's high was 1.34% on 15 Mar 2023 and its low 0.88% on 13 Jan 2023, averaging 1.07% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.28 days on 14 Jul 2023. Full history: Nuvation Bio Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 0.88% (13 Jan 2023)
- End of year
- 1.08% (29 Dec 2023)
- Change
- +0.20 pp
- High
- 1.34% (15 Mar 2023)
- Low
- 0.88% (13 Jan 2023)
- Average
- 1.07%
- Highest days to cover
- 11.28 (14 Jul 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 0.88% | 1.80 | |
| 31 Jan 2023 | 0.97% | 4.99 | |
| 15 Feb 2023 | 1.01% | 6.49 | |
| 28 Feb 2023 | 1.13% | 4.08 | |
| 15 Mar 2023 | 1.34% | 4.82 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 1.15% | 2.93 | |
| 14 Apr 2023 | 1.06% | 5.67 | |
| 28 Apr 2023 | 1.05% | 7.14 | |
| 15 May 2023 | 0.95% | 4.89 | 10-Q filed, results (8-K) |
| 31 May 2023 | 0.92% | 3.80 | |
| 15 Jun 2023 | 0.97% | 5.42 | |
| 30 Jun 2023 | 1.33% | 3.61 | |
| 14 Jul 2023 | 1.20% | 11.28 | |
| 31 Jul 2023 | 1.13% | 3.88 | |
| 15 Aug 2023 | 1.08% | 4.31 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 0.99% | 10.54 | |
| 15 Sep 2023 | 1.10% | 5.08 | |
| 29 Sep 2023 | 1.00% | 1.43 | |
| 13 Oct 2023 | 0.97% | 4.11 | |
| 31 Oct 2023 | 1.10% | 1.06 | |
| 15 Nov 2023 | 0.98% | 1.00 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 1.21% | 1.99 | |
| 15 Dec 2023 | 1.01% | 2.59 | |
| 29 Dec 2023 | 1.08% | 3.30 |
See also: Nuvation Bio Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.